Literature DB >> 16331780

Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil.

Christopher Lee Colglazier1, Paul G Sutej, Kenneth S O'Rourke.   

Abstract

Systemic sclerosis (scleroderma) is a multisystem fibrotic disease that commonly manifests with severe Raynaud's phenomenon and slow-healing cutaneous ulcerations. Reduced nitric oxide levels have been proposed to play a role in the pathogenesis of vascular disease in scleroderma, and therefore sildenafil (which increases nitric oxide levels) is an attractive therapeutic prospect. We describe a patient with limited cutaneous systemic sclerosis who presented with severe nonhealing finger ulcerations despite conventional management, who showed marked improvement with oral sildenafil.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331780

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  Recent advances on pathogenesis and therapies in systemic sclerosis.

Authors:  Norihito Yazawa; Manabu Fujimoto; Kunihiko Tamaki
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

2.  Tadalafil therapy and severe chronic foot wound resolution.

Authors:  Claire Davenport; Andrew Dubin
Journal:  Int Wound J       Date:  2015-02-03       Impact factor: 3.315

3.  Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers.

Authors:  S Blaise; M Hellmann; M Roustit; S Isnard; J L Cracowski
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study.

Authors:  Kellen L Meadows; Christel Rushing; Wanda Honeycutt; Kenneth Latta; Leigh Howard; Christy A Arrowood; Donna Niedzwiecki; Herbert I Hurwitz
Journal:  Support Care Cancer       Date:  2014-10-24       Impact factor: 3.603

5.  Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.

Authors:  Wendy Ky Ng; Yishai Rosenblatt; Gerald B Brock; David B O'Gorman; Bing Siang Gan
Journal:  Can J Plast Surg       Date:  2010

6.  Platelet gel in the treatment of severe scleroderma skin ulcers.

Authors:  Dilia Giuggioli; Michele Colaci; Andreina Manfredi; Mariateresa Mariano; Clodoveo Ferri
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

Review 7.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

8.  Digital ischemia in scleroderma spectrum of diseases.

Authors:  Elena Schiopu; Ann J Impens; Kristine Phillips
Journal:  Int J Rheumatol       Date:  2010-08-31

9.  [Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil].

Authors:  E Friedrichson; P Rehberger; J T Fuhrmann; F Walz; M Meurer; C Pfeiffer
Journal:  Hautarzt       Date:  2008-03       Impact factor: 1.198

10.  Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study.

Authors:  Claudia S Brueckner; Mike O Becker; Thomas Kroencke; Doerte Huscher; Hans Ulrich Scherer; Margitta Worm; Gerd Burmester; Gabriela Riemekasten
Journal:  Ann Rheum Dis       Date:  2009-11-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.